Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001894562-25-000018
Filing Date
2025-05-12
Accepted
2025-05-12 16:48:33
Documents
3
Period of Report
2025-05-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1747082905.html 4  
1 FORM 4 wk-form4_1747082905.xml 4 4139
2 EX-24 primemedicine-powerofatt.htm EX-24 5162
3 GRAPHIC primemedicine-powerofatt001.jpg GRAPHIC 307378
  Complete submission text file 0001894562-25-000018.txt   434180
Mailing Address 400 DEXTER AVENUE NORTH SUITE 1200 SEATTLE WA 98109
Business Address
LEE ANN L. (Reporting) CIK: 0001723629 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41536 | Film No.: 25935660

Mailing Address 60 FIRST ST. CAMBRIDGE MA 02141
Business Address 60 FIRST ST. CAMBRIDGE MA 02141 617-465-0013
Prime Medicine, Inc. (Issuer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)